Dynoma Biosciences
Dynoma Biosciences provides real-time research platforms that visualize and quantify dynamic biomolecular interactions, including alternative DNA/RNA structures and protein conformational changes. The company's technology delivers 98% assay resolution and ten-fold higher target throughput, enabling genome-wide mapping of nucleic-acid structures to accelerate drug discovery for complex therapeutic targets.
- Drug Discovery & Therapeutics
- Biotechnology
Funding
Founders
Founder details are not available yet.
Product
Problem
Conventional biological research methods provide only static snapshots of molecular events, yet nucleic acids continuously change their structure and accessibility, proteins transition between functional states, and biomolecules form transient interactions that regulate cellular behavior. These dynamic processes are fundamental to gene regulation, disease development, and therapeutic response, but remain largely inaccessible with existing tools, limiting drug discovery for complex targets.
Solution
Dynoma Biosciences develops innovative research platforms and molecular technologies designed to capture, map, and manipulate dynamic molecular states in real time. The company's platforms visualize and quantify dynamic biomolecular interactions, including alternative DNA/RNA structures, protein–nucleic acid interactions, and protein conformational changes. By integrating molecular biology, genomics, protein science, chemical biology, and drug discovery, Dynoma enables genome-wide mapping of alternative nucleic acid structures and molecular switches that inform therapeutic development. The technology delivers 98% assay resolution and ten-fold higher target throughput, providing pharmaceutical teams with quantitative, real-time dynamic mapping to identify and validate novel mechanisms of action.
Target Audience
Primary customers are pharmaceutical and biotechnology research teams focused on drug discovery for complex targets, as well as academic researchers investigating dynamic biomolecular interactions, alternative nucleic acid structures, and RNA biology.
Features
- Real-time platforms for visualizing and quantifying dynamic biomolecular interactions, including alternative DNA/RNA structures and protein conformational changes
- Genome-wide mapping capabilities for alternative DNA/RNA structures and pharmaceutical/molecular switches of RNA and protein dynamics
- 98% assay resolution and 10x target throughput compared to conventional approaches
- Integration of molecular biology, genomics, protein science, chemical biology, and drug discovery in a unified research platform
- Foundational research published in leading scientific journals validating platform capabilities
- Intellectual property portfolio protecting novel methods for biomolecular analysis and target validation